Dr. Alexander Eugene Loscialpo, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3801 Katella Ave, 201, Los Alamitos, CA 90720 Phone: 562-594-8831 Fax: 562-594-8832 |
Dr. Dennis Carl Jerome, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3801 Katella Ave, Suite 201, Los Alamitos, CA 90720 Phone: 714-892-7735 Fax: 562-594-8832 |
News Archive
Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.
Anaplastic large-cell lymphomas are rare cancers of the white blood cells. New research from the international ERIA consortium, led by scientists in Vienna, has now shown that the same signaling pathway is essential to the growth of cancer cells in various forms of ALCL: TYK2 (tyrosine kinase 2, an important component of the immune system) prevents apoptotic cell death by increasing the production of Mcl1, a special type of protein belonging to the BCL2 family.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).
The U.S. Food and Drug Administration (FDA) has ordered Johnson & Johnson and C.R. Bard Inc. to study rates of organ damage, infection and painful sex linked to vaginal mesh implants, in response to doctors and patients who say the devices have harmed women.
› Verified 6 days ago